⌘K

Login Start Free

Home/Filings/4/0001104659-24-042053

4//SEC Filing

Hohneker John 4

Accession 0001104659-24-042053

CIK 0001485003other

View on SEC.gov Company Profile

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 6:59 PM ET

Size

5.7 KB

Accession

0001104659-24-042053

Insider Transaction Report

Form 4

Period: 2024-04-01

Carisma Therapeutics Inc.CARM

Director

Transactions

Award
Stock Option (Right to Buy)
2024-04-01+38,700→ 38,700 total
Exercise: $2.09Exp: 2034-04-01→ Common Stock (38,700 underlying)

Footnotes (1)

[F1]The shares underlying this option vest over three years in equal monthly installments following April 1, 2024, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.

Documents

1 file

4
tm2410345-2_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Carisma Therapeutics Inc.

CIK 0001485003

Entity typeother

Related Parties

1

filerCIK 0001695378

Filing Metadata

Form type: 4
Filed: Mar 31, 8:00 PM ET
Accepted: Apr 1, 6:59 PM ET
Size: 5.7 KB

View on SEC.gov